Merger and Acquisition Deals and Alliances of 2014 - Worldwide Industry Size, Share, Trend, Growth, Analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

The Merger and Acquisition Deals of 2014 provides comprehensive understanding and unprecedented access to the M&A deals and agreements entered into by the worlds leading healthcare companies during 2014.

Using these reports, dealmakers will effectively and efficiently gain insight into the M&A activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.

To Download Sample Report With TOC: http://www.researchmoz.com/enquiry.php?type=sample&repid=264252

The initial chapters of this report provide an orientation of 2014’s M&A dealmaking and business activities.

Chapter 1 provides an overview of the trends in M&A dealmaking during 2014.

Chapter 2 provides a review of the leading M&A deals during 2014. Deals are listed by headline value, signed by big pharma and big biotech, and most active biopharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 3 provides a comprehensive listing of the top 50 big pharma companies with a brief summary followed by a comprehensive listing of 2014 M&A deals, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a comprehensive directory of all M&A deals announced during 2014.

The chapter is organized by company A-Z. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report series also includes numerous tables and figures that illustrate the trends and activities in bigpharma M&A dealmaking during 2014....